The European Medicines Agency recommends approval of an intramuscular injection gene therapy, alipogene tiparvovec (Glybera by uniQure) for a rare genetic disorder, called lipoprotein lipase deficiency. Final approval is still required from the European Commission. Controversy follows gene therapy and such therapy has yet to be approved in Europe and North America. Approval could open the door to many other gene therapies on the horizon. What are your thoughts regarding gene therapy?